Top experts by indication / Oncology
Most active experts in Small Cell Lung Carcinoma
2026 edition, data as of October 26, 2026
338 key opinion leaders in the directory are tagged to Small Cell Lung Carcinoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 332 of the 338 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | David SpigelSarah Cannon Research Institute, TN | 20 trials |
| 2 | Alexander SpiraVirginia Cancer Specialists, VA | 13 trials |
| 3 | Daniel MorgenszternWashington University School of Medicine in St. Louis, MO | 13 trials |
| 4 | Melissa JohnsonUniversity of California, San Diego, TN | 12 trials |
| 5 | Pasi JanneDana-Farber Cancer Institute, MA | 11 trials |
| 6 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 11 trials |
| 7 | Nasser HannaIndiana University School of Medicine, IN | 11 trials |
| 8 | Alex AdjeiMN | 10 trials |
| 9 | Chandra BelaniPA | 9 trials |
| 10 | Lecia SequistMA | 7 trials |
| 11 | Neal ReadyDuke University School of Medicine, NC | 7 trials |
| 12 | Alberto ChiapporiMoffitt Cancer Center, FL | 7 trials |
| 13 | Saiama WaqarWashington University School of Medicine in St. Louis, MO | 7 trials |
| 14 | Nitin OhriMontefiore Einstein, PA | 7 trials |
| 15 | Jared WeissUniversity of North Carolina at Chapel Hill, NC | 7 trials |
| 16 | Heather WakeleeStanford University School of Medicine, CA | 7 trials |
| 17 | Thomas StinchcombeDuke University School of Medicine, NC | 7 trials |
| 18 | Anne TraynorUniversity of Wisconsin–Madison, WI | 7 trials |
| 19 | Helena YuCA | 6 trials |
| 20 | Mark SocinskiAdventHealth Cancer Institute, FL | 6 trials |
| 21 | Jonathan GoldmanUniversity of California, Los Angeles, CA | 6 trials |
| 22 | Edward GaronUniversity of California, Los Angeles, CA | 6 trials |
| 23 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 6 trials |
| 24 | Enriqueta FelipVall d'Hebron Institute of Oncology (VHIO) | 5 trials |
| 25 | David CamidgeUniversity of Colorado Hospital, CO | 5 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 112 of the 338 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Pasi JanneDana-Farber Cancer Institute, MA | 127,638 citations |
| 2 | Julie BrahmerJohns Hopkins University School of Medicine, MD | 124,810 citations |
| 3 | Enriqueta FelipVall d'Hebron Institute of Oncology (VHIO) | 110,546 citations |
| 4 | Suresh RamalingamEmory University, GA | 106,346 citations |
| 5 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 98,957 citations |
| 6 | Gregory RielyMemorial Sloan Kettering Cancer Center, NY | 96,674 citations |
| 7 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 88,594 citations |
| 8 | Everett VokesUniversity of Chicago, IL | 80,021 citations |
| 9 | David SpigelSarah Cannon Research Institute, TN | 79,383 citations |
| 10 | Giuseppe GiacconeWeill Cornell Medicine, MD | 74,199 citations |
| 11 | Howard BurrisSarah Cannon Research Institute, TN | 72,593 citations |
| 12 | John HeymachThe University of Texas MD Anderson Cancer Center, TX | 69,203 citations |
| 13 | Nathan PennellCleveland Clinic, OH | 69,047 citations |
| 14 | Taofeek OwonikokoUniversity of Maryland School of Medicine, MD | 66,624 citations |
| 15 | Naiyer RizviSynthekine, NY | 65,566 citations |
| 16 | Mitesh BoradMayo Clinic, AZ | 60,996 citations |
| 17 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 59,091 citations |
| 18 | Maximilian DiehnStanford University School of Medicine, CA | 56,961 citations |
| 19 | Edward GaronUniversity of California, Los Angeles, CA | 56,135 citations |
| 20 | David GandaraUniversity of California, Davis, CA | 55,117 citations |
| 21 | Ravi SalgiaCity of Hope, CA | 48,747 citations |
| 22 | David HongThe University of Texas MD Anderson Cancer Center, TX | 47,734 citations |
| 23 | Shirish GadgeelHenry Ford Health System, MI | 43,144 citations |
| 24 | Corey LangerUniversity of Pennsylvania, PA | 40,136 citations |
| 25 | Mark SocinskiAdventHealth Cancer Institute, FL | 36,990 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 82 of the 338 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | William CarsonThe Ohio State University, OH | 19 awards |
| 2 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 13 awards |
| 3 | Evanthia GalanisMayo Clinic, MN | 13 awards |
| 4 | Harriet KlugerYale School of Medicine, CT | 11 awards |
| 5 | Maximilian DiehnStanford University School of Medicine, CA | 11 awards |
| 6 | Pasi JanneDana-Farber Cancer Institute, MA | 10 awards |
| 7 | John HeymachThe University of Texas MD Anderson Cancer Center, TX | 10 awards |
| 8 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 10 awards |
| 9 | Jennifer TemelMassachusetts General Hospital, MA | 10 awards |
| 10 | Suresh RamalingamEmory University, GA | 9 awards |
| 11 | David GandaraUniversity of California, Davis, CA | 7 awards |
| 12 | Roman Perez-SolerNY | 7 awards |
| 13 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 7 awards |
| 14 | Alex AdjeiMN | 6 awards |
| 15 | Primo LaraUniversity of California, Davis, CA | 6 awards |
| 16 | Anne TraynorUniversity of Wisconsin–Madison, WI | 6 awards |
| 17 | Gerold BeplerWayne State University, MI | 6 awards |
| 18 | Everett VokesUniversity of Chicago, IL | 5 awards |
| 19 | Michael KelleyNC | 5 awards |
| 20 | Lecia SequistMA | 5 awards |
| 21 | Steven LinThe University of Texas MD Anderson Cancer Center, TX | 5 awards |
| 22 | Faye JohnsonTX | 4 awards |
| 23 | David HongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 24 | Clifford RobinsonWashington University School of Medicine in St. Louis, MO | 4 awards |
| 25 | Taofeek OwonikokoUniversity of Maryland School of Medicine, MD | 4 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 61 of the 338 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Erika HamiltonSarah Cannon Research Institute, TN | 364 contributions |
| 2 | Johanna BendellPfizer, TN | 310 contributions |
| 3 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 4 | Primo LaraUniversity of California, Davis, CA | 264 contributions |
| 5 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 6 | Siqing FuThe University of Texas MD Anderson Cancer Center, TX | 241 contributions |
| 7 | Cathy EngVanderbilt University Medical Center, TN | 240 contributions |
| 8 | Lee SchwartzbergRenown Institute for Cancer, NV | 238 contributions |
| 9 | Maximilian DiehnStanford University School of Medicine, CA | 231 contributions |
| 10 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 11 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 210 contributions |
| 12 | Steven LinThe University of Texas MD Anderson Cancer Center, TX | 203 contributions |
| 13 | Jennifer TemelMassachusetts General Hospital, MA | 202 contributions |
| 14 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 197 contributions |
| 15 | Shirish GadgeelHenry Ford Health System, MI | 196 contributions |
| 16 | Corey LangerUniversity of Pennsylvania, PA | 192 contributions |
| 17 | Taofeek OwonikokoUniversity of Maryland School of Medicine, MD | 188 contributions |
| 18 | Mark SocinskiAdventHealth Cancer Institute, FL | 182 contributions |
| 19 | Clifford RobinsonWashington University School of Medicine in St. Louis, MO | 178 contributions |
| 20 | Ahmad TarhiniMoffitt Cancer Center, PA | 174 contributions |
| 21 | Gregory RielyMemorial Sloan Kettering Cancer Center, NY | 173 contributions |
| 22 | Heather WakeleeStanford University School of Medicine, CA | 167 contributions |
| 23 | Julie BrahmerJohns Hopkins University School of Medicine, MD | 165 contributions |
| 24 | Mark AwadMemorial Sloan Kettering Cancer Center, NY | 161 contributions |
| 25 | Nasser HannaIndiana University School of Medicine, IN | 158 contributions |
Emerging
12 of the 338 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX |
| Cathy EngVanderbilt University Medical Center, TN |
| Barbara GitlitzUniversity of Southern California, CA |
| Herbert HurwitzDuke University, NC |
| Samir KhleifGeorgetown University School of Medicine, GA |
| Gottfried KonecnyUniversity of California, Los Angeles, CA |
| Evan LipsonJohns Hopkins University School of Medicine, MD |
| Fabien MaldonadoVanderbilt University Medical Center, TN |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Salman PunekarNYU Langone Health, NY |
| Andreas SaltosMoffitt Cancer Center, FL |
| Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX |
How these tables are computed
The cohort is every profile in the directory tagged to Small Cell Lung Carcinoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Small Cell Lung Carcinoma profile in the directory